Alpine Immune Sciences Inc (NASDAQ:ALPN)

8.17
Delayed Data
As of Jun 19
 -0.08 / -0.97%
Today’s Change
6.85
Today|||52-Week Range
12.87
-27.05%
Year-to-Date
No recent news for Alpine Immune Sciences Inc.

Today’s Trading

Previous close8.25
Today’s open8.25
Day’s range8.10 - 8.34
Volume6,817
Average volume (3 months)21,709
Market cap$110.5M
Data as of 4:00pm ET, 06/19/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-59.58%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio4.9
Price/Sales41.94
Price/Book1.40

Competitors

 Today’s
change
Today’s
% change
NVIVInVivo Therapeutics ...-0.22-4.56%
CLBSCaladrius Bioscience...+2.66+67.34%
MTEMMolecular Templates ...+0.06+1.15%
CSBRChampions Oncology I...+0.32+5.08%
Data as of 4:00pm ET, 06/19/2018

Financials

Next reporting dateJuly 31, 2018
EPS forecast (this quarter)-$0.46
Annual revenue (last year)$1.7M
Annual profit (last year)-$7.8M
Net profit margin-449.62%

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman &
Chief Executive Officer
Mitchell H. Gold
President &
Director
Jay Venkatesan
Corporate headquarters
Seattle, Washington

Forecasts